How InvestingPro’s Fair Value spotted 66% upside in Cimpress stock By Investing.com

Cimpress rallied from $48.19 in February 2025 to $81.18 in April 2026, generating a 66.2% total return and beating the $80.09 fair value target. The article cites improving fundamentals, with revenue up 6.2% to $3.56 billion and EBITDA up 7.6% to $330.8 million, plus a $200 million buyback authorization and insider buying by CFO Sean Quinn. Truist also reiterated a Buy rating with a $100 price target, reinforcing the bullish valuation case.

Analysis

CMPR is still in the part of the cycle where operating leverage matters more than headline revenue growth: buybacks, insider alignment, and incremental margin expansion can keep EPS compounding even if top-line growth stays mid-single digits. The market is likely still underappreciating how much repurchases can magnify per-share value creation for a company with durable cash generation and limited need for heavy capex.

The second-order winner is not just CMPR but its capital-allocation profile relative to slower-growing software/marketing peers that lack the same flexibility. If management sustains the repurchase pace, the stock can continue to rerate as the public float tightens and every incremental beat flows through to EPS and free cash flow yield; that dynamic tends to persist for multiple quarters, not days.

The main risk is that the current move has already validated the bullish thesis, so the easy multiple expansion may be behind it. From here, the setup becomes a question of whether fundamental compounding can outrun expectations; any slowdown in order volumes, evidence of weaker SMB demand, or a pause in buybacks would likely hit the stock harder than the market currently prices in.

Consensus may be missing that this is less a simple "undervalued stock" story and more a balance-sheet-supported re-rating story. That means the best upside usually comes when skepticism is still high and repurchases are absorbing supply; once the stock approaches prior highs, the forward return profile becomes more dependent on execution and less on mispricing correction.

Key Decisions for Investors

• Maintain/establish a tactical long CMPR into pullbacks over the next 2-6 weeks; target another 10-15% upside if buybacks continue to shrink float and earnings revisions stay positive.
• Use a call spread in CMPR rather than outright equity for the next 3-6 months; this captures rerating upside while limiting drawdown if the stock stalls near prior highs.
• If already long, take partial profits into strength above the recent range and trail the remainder; risk/reward deteriorates as the valuation gap closes and the stock becomes more execution-sensitive.
• Pair CMPR long against a lower-quality, higher-beta small-cap marketing/print peer basket over the next quarter; the cleaner cash return story should outperform if risk appetite weakens.
• Watch for any pause in repurchases or insider selling as a de-risk signal; that would be the first indication that the current per-share compounding narrative is fading.